New Mexico Educational Retirement Board lifted its position in shares of MAXIMUS, Inc. (NYSE:MMS) by 38.2% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 15,200 shares of the health services provider’s stock after buying an additional 4,200 shares during the period. New Mexico Educational Retirement Board’s holdings in MAXIMUS were worth $885,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Valeo Financial Advisors LLC purchased a new position in MAXIMUS during the first quarter worth about $27,000. First Quadrant L P CA acquired a new stake in MAXIMUS in the first quarter valued at $154,000. Advisor Group Holdings Inc. acquired a new stake in MAXIMUS in the first quarter valued at $160,000. Value Holdings Management CO. LLC acquired a new stake in MAXIMUS in the first quarter valued at $174,000. Finally, World Asset Management Inc acquired a new stake in MAXIMUS in the first quarter valued at $200,000. Hedge funds and other institutional investors own 94.71% of the company’s stock.

Several analysts recently issued reports on the stock. TheStreet cut shares of MAXIMUS from a “b” rating to a “c+” rating in a report on Friday, March 13th. KeyCorp raised shares of MAXIMUS from a “sector weight” rating to an “overweight” rating and set a $80.00 price target on the stock in a report on Wednesday, June 24th. Four research analysts have rated the stock with a hold rating and one has given a buy rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus target price of $79.25.

MMS stock opened at $71.15 on Tuesday. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.97 and a quick ratio of 1.97. MAXIMUS, Inc. has a 1-year low of $46.42 and a 1-year high of $82.02. The firm has a fifty day moving average price of $69.80 and a two-hundred day moving average price of $68.35. The firm has a market cap of $4.26 billion, a price-to-earnings ratio of 21.96 and a beta of 0.92.

MAXIMUS (NYSE:MMS) last released its earnings results on Thursday, May 7th. The health services provider reported $0.43 earnings per share for the quarter, missing the consensus estimate of $0.82 by ($0.39). MAXIMUS had a net margin of 6.71% and a return on equity of 17.09%. The business had revenue of $818.10 million for the quarter, compared to the consensus estimate of $770.28 million. During the same quarter in the previous year, the firm earned $0.96 EPS. The firm’s revenue for the quarter was up 11.1% on a year-over-year basis. As a group, analysts expect that MAXIMUS, Inc. will post 3.02 EPS for the current fiscal year.

In other news, Vice Chairman Richard A. Montoni sold 31,398 shares of the company’s stock in a transaction dated Thursday, June 11th. The shares were sold at an average price of $67.91, for a total transaction of $2,132,238.18. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Vice Chairman Richard A. Montoni sold 10,466 shares of the company’s stock in a transaction dated Tuesday, June 9th. The stock was sold at an average price of $72.84, for a total transaction of $762,343.44. The disclosure for this sale can be found here. 2.00% of the stock is owned by insiders.

MAXIMUS Profile

MAXIMUS, Inc provides business process services (BPS) to government health and human services programs worldwide. The company's Health Services segment offers various BPS, appeals, and assessments for state, provincial, and national government programs, including Medicaid, Children's Health Insurance Program, Affordable Care Act, Health Insurance British Columbia, Health Assessment Advisory Service contract, and Preadmission Screening and Resident Reviews.

Featured Article: Short Selling

Institutional Ownership by Quarter for MAXIMUS (NYSE:MMS)

Receive News & Ratings for MAXIMUS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAXIMUS and related companies with MarketBeat.com's FREE daily email newsletter.